-
Je něco špatně v tomto záznamu ?
Allopregnanolone and pregnanolone analogues modified in the C ring: synthesis and activity
B. Slavíková, J. Bujons, L. Matyáš, M. Vidal, Z. Babot, Z. Krištofíková, C. Suñol, A. Kasal,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
23421641
DOI
10.1021/jm3016365
Knihovny.cz E-zdroje
- MeSH
- konformace proteinů MeSH
- kvantitativní vztahy mezi strukturou a aktivitou * MeSH
- molekulární modely MeSH
- myši MeSH
- neurony metabolismus MeSH
- pregnanolon analogy a deriváty chemická syntéza metabolismus MeSH
- receptory GABA-A chemie metabolismus MeSH
- techniky syntetické chemie MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
(25R)-3β-Hydroxy-5α-spirostan-12-one (hecogenin) and 11α-hydroxypregn-4-ene-3,20-dione (11α-hydroxyprogesterone) were used as starting materials for the synthesis of a series of 11- and 12-substituted derivatives of 5ξ-pregnanolone (3α-hydroxy-5α-pregnan-20-one and 3α-hydroxy-5β-pregnan-20-one), the principal neurosteroid acting via γ-aminobutyric acid (GABA). These analogues were designed to study the structural requirements of the corresponding GABAA receptor. Their biological activity was measured by in vitro test with [(3)H]flunitrazepam as radioligand in which allopregnanolone and its active analogues stimulated the binding to the GABAA receptor. Analysis of the SAR data suggests dependence of the flunitrazepam binding activity on the hydrophobic-hydrophilic balance of the groups at the C-ring edge rather than on specific interactions between them and the receptor.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13023952
- 003
- CZ-PrNML
- 005
- 20130710115427.0
- 007
- ta
- 008
- 130703s2013 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/jm3016365 $2 doi
- 035 __
- $a (PubMed)23421641
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Slavíková, Barbora $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 166 10 Prague 6, Czech Republic.
- 245 10
- $a Allopregnanolone and pregnanolone analogues modified in the C ring: synthesis and activity / $c B. Slavíková, J. Bujons, L. Matyáš, M. Vidal, Z. Babot, Z. Krištofíková, C. Suñol, A. Kasal,
- 520 9_
- $a (25R)-3β-Hydroxy-5α-spirostan-12-one (hecogenin) and 11α-hydroxypregn-4-ene-3,20-dione (11α-hydroxyprogesterone) were used as starting materials for the synthesis of a series of 11- and 12-substituted derivatives of 5ξ-pregnanolone (3α-hydroxy-5α-pregnan-20-one and 3α-hydroxy-5β-pregnan-20-one), the principal neurosteroid acting via γ-aminobutyric acid (GABA). These analogues were designed to study the structural requirements of the corresponding GABAA receptor. Their biological activity was measured by in vitro test with [(3)H]flunitrazepam as radioligand in which allopregnanolone and its active analogues stimulated the binding to the GABAA receptor. Analysis of the SAR data suggests dependence of the flunitrazepam binding activity on the hydrophobic-hydrophilic balance of the groups at the C-ring edge rather than on specific interactions between them and the receptor.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a techniky syntetické chemie $7 D060326
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a neurony $x metabolismus $7 D009474
- 650 _2
- $a pregnanolon $x analogy a deriváty $x chemická syntéza $x metabolismus $7 D011280
- 650 _2
- $a konformace proteinů $7 D011487
- 650 12
- $a kvantitativní vztahy mezi strukturou a aktivitou $7 D021281
- 650 _2
- $a receptory GABA-A $x chemie $x metabolismus $7 D011963
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bujons, Jordi $u -
- 700 1_
- $a Matyáš, Libor $u -
- 700 1_
- $a Vidal, Miguel $u -
- 700 1_
- $a Babot, Zoila $u -
- 700 1_
- $a Krištofíková, Zdena $u -
- 700 1_
- $a Suñol, Cristina $u -
- 700 1_
- $a Kasal, Alexander $u -
- 773 0_
- $w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 56, č. 6 (2013), s. 2323-36
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23421641 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130703 $b ABA008
- 991 __
- $a 20130710115850 $b ABA008
- 999 __
- $a ok $b bmc $g 987632 $s 822332
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 56 $c 6 $d 2323-36 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
- LZP __
- $a Pubmed-20130703